Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

At the beginning of the pandemic, we observed that lithium carbonate had a positive effect on the recovery of severely ill patients with COVID-19. Lithium is able to inhibit the replication of several types of viruses, some of which are similar to the SARS-CoV-2 virus, increase the immune response a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Carlos Spuch, Marta López-García, Tania Rivera-Baltanás, J. J Cabrera-Alvargonzález, Sudhir Gadh, Daniela Rodrigues-Amorim, Tania Álvarez-Estévez, Almudena Mora, Marta Iglesias-Martínez-Almeida, Luis Freiría-Martínez, Maite Pérez-Rodríguez, Alexandre Pérez-González, Ana López-Domínguez, María Rebeca Longueira-Suarez, Adrián Sousa-Domínguez, Alejandro Araújo-Ameijeiras, David Mosquera-Rodríguez, Manuel Crespo, Dolores Vila-Fernández, Benito Regueiro, Jose Manuel Olivares
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2022-04-01
Sarja:Frontiers in Pharmacology
Aiheet:
COVID-19
SARS-CoV-2
clinical trial
inflammation
lithium carbonate
Linkit:https://www.frontiersin.org/articles/10.3389/fphar.2022.850583/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia